A compound originally developed as a cancer treatment may hold promise for treating polycystic kidney disease (ADPKD), which affects more than half a million Americans and can lead to kidney enlargement and loss of function.
— Read on news.mit.edu/2024/new-drug-candidate-can-shrink-kidney-cysts-0122
